Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.016 EUR
7.54 M EUR
60.66 M EUR
427.64 M
About EKF Diagnostics Holdings plc
Sector
Industry
CEO
Gavin Joseph Jones
Website
Headquarters
Penarth
Founded
2002
ISIN
GB0031509804
FIGI
BBG000QWK8C7
EKF Diagnostics Holdings Plc is a vitro diagnostics company, which engages in the designs and manufactures diagnostic equipment for use within point-of-care settings. It operates through the following geographical segments: Germany, USA, Russia, and the United Kingdom. The company was founded in 1990 and is headquartered in Penarth, the United Kingdom.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EKF Diagnostics Holdings plc stocks are traded under the ticker LYF.
We've gathered analysts' opinions on EKF Diagnostics Holdings plc future price: according to them, LYF price has a max estimate of 0.43 EUR and a min estimate of 0.39 EUR. Watch LYF chart and read a more detailed EKF Diagnostics Holdings plc stock forecast: see what analysts think of EKF Diagnostics Holdings plc and suggest that you do with its stocks.
Yes, you can track EKF Diagnostics Holdings plc financials in yearly and quarterly reports right on TradingView.
EKF Diagnostics Holdings plc is going to release the next earnings report on Mar 31, 2026. Keep track of upcoming events with our Earnings Calendar.
LYF earnings for the last half-year are 0.01 EUR per share, whereas the estimation was 0.01 EUR, resulting in a −14.00% surprise. The estimated earnings for the next half-year are 0.01 EUR per share. See more details about EKF Diagnostics Holdings plc earnings.
EKF Diagnostics Holdings plc revenue for the last half-year amounts to 29.41 M EUR, despite the estimated figure of 29.37 M EUR. In the next half-year revenue is expected to reach 30.01 M EUR.
LYF net income for the last half-year is 2.27 M EUR, while the previous report showed 5.05 M EUR of net income which accounts for −55.11% change. Track more EKF Diagnostics Holdings plc financial stats to get the full picture.
EKF Diagnostics Holdings plc dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 2, 2025, the company has 303 employees. See our rating of the largest employees — is EKF Diagnostics Holdings plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EKF Diagnostics Holdings plc EBITDA is 13.32 M EUR, and current EBITDA margin is 22.28%. See more stats in EKF Diagnostics Holdings plc financial statements.
Like other stocks, LYF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EKF Diagnostics Holdings plc stock right from TradingView charts — choose your broker and connect to your account.